• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

AVRIO Health

  • Home
  • About Avrio Health
  • Our Products
  • Careers
  • News
  • Contact Us

Avrio Health Announces Manuscript Publication of Research Evaluating the In Vitro Inactivation of SARS CoV 2 Using Betadine® Antiseptic Oral Rinse in BMC Oral Health.

March 28, 2022 by Rahul Majumdar

It is important to note that in vivo (human/animal) studies have not been conducted to evaluate the effectiveness of Betadine® antiseptics in the prevention or treatment of SARS-CoV-2 infection, nor have any human clinical studies been conducted to assess its safety or effectiveness as a virucidal agent.

Betadine® Antiseptic Oral Rinse (Povidone Iodine 0.5%) is used by healthcare professionals for pre-procedural preparation of the oral mucosa. This product should not be ingested. Use Betadine products only as directed on the label.

STAMFORD, Conn. – March 28, 2022 – Avrio Health L.P. today announced the publication of its manuscript, In vitro inactivation of SARS‑CoV‑2 using a povidone‑iodine oral rinse in the journal BioMed Central (BMC) Oral Health. The study was conducted at Utah State University, Institute for Antiviral Research and included Avrio’s Betadine® oral antiseptic product, povidone-iodine 0.5% solution.1

The research demonstrated in vitro (cell culture) virucidal activity of 0.5% povidone iodine solution against SARS-CoV-2, the virus that causes COVID-19. Inactivation of SARS-CoV-2 was observed as early as 15 seconds after exposure to the povidone iodine solution.

“While clinical investigations are needed to assess the effectiveness of Betadine® Antiseptic Oral Rinse against SARS-CoV-2 in clinical practice, this study demonstrates promising initial results,” said Julie Ducharme, BPharm, MSc, PhD, vice president and chief scientific officer.

About Betadine®
Betadine® Topical Antiseptic products have been used in the hospital and outpatient setting for their antimicrobial properties for more than 50 years. Betadine® Topical Antiseptic products currently available in the U.S. are for external use only and should not be gargled or swallowed. Use only as directed on the label. Betadine® Antiseptic Sore Throat Gargle (povidone iodine 0.5%), which should not be ingested, is used for the temporary relief of sore throat. Betadine® Antiseptic Oral Rinse (povidone iodine 0.5%) is used by healthcare professionals for pre-procedural preparation of the oral mucosa.

About Avrio Health L.P.
Avrio Health L.P. is a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions. We have a strong portfolio of well-respected and proven effective brands, including Betadine®, Colace®, Senokot®, and SlowMag® Mg.

Media Contact:
Michele Sharp
(203) 588-7584

1 Shet et al. BMC Oral Health (2022) 22:47 https://doi.org/10.1186/s12903-022-02082-9

Filed Under: Press Releases

Primary Sidebar

Footer

  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Information
Avrio Health L.P. is a wholly owned a subsidiary of Purdue Pharma L.P.
© 2019 Avrio Health L.P.
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Information
Avrio Health L.P. is a wholly owned a subsidiary of Purdue Pharma L.P.
© 2019 Avrio Health L.P.

Copyright © 2023 Avrio Health L.P. MR-05157

Copyright © 2023 · Avrio Health on Genesis Framework · WordPress · Log in

  • Home
  • About Avrio Health
  • Our Products
  • Careers
  • News
  • Contact Us